Verthermia-preview

Verthermia

Private

Dallas, TexasHealthcare & Life Scienceshttps://verthermia.com/

Last Round

VC Round

Jan 11, 2021

Total Funding Raised

$1.62M

Company Overview

Verthermia is a biotechnology company that provides HEATT® (Hyperthermic Extracorporeal Applied Tumor Therapy), a proprietary whole-body hyperthermia treatment technology designed to treat cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Non-AI

Keywords

whole-body hyperthermiacancer treatmentHEATTmedical devicemetastatic cancer treatmentheat therapy for cancerHyperthermic Extracorporeal Applied Tumor Therapyadvanced cancer treatmentlast resort cancer treatmentintegrative oncologyextracorporeal therapyperfusion equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Verthermia Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Verthermia Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jan 11, 2021
Convertible Debt	Jul 1, 2019
Convertible Debt	Dec 1, 2016

View all Funding Rounds

Key People

Founding team and executive leadership

David E. Wilder

Chief Financial Officer

Executive Team

Verthermia Investors

Notable investors and investment history

Investor	Rounds
COVA Capital Partners	Convertible Debt, VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 1, 2025
Monthly visitors increased 38% MoM.
Nov 29, 2024
Monthly visitors increased 113% MoM.

View all signals

Verthermia Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Verthermia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Verthermia's valuation, stock price, and market status.

Firmographic Details

HeadquartersDallas, Texas

Employee Range2

Year Founded2012

Last FundingJan 11, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.